TABLE 2.
Patient disease and treatment characteristics (N = 100)
| Diagnosis | |
|---|---|
| Malignancy a | 73% (73) |
| Premalignancy b | 9% (9) |
| Benign c | 12% (12) |
| Osteoradionecrosis | 3% (3) |
| Diagnosis pending | 3% (3) |
| Primary site | |
| Skin | 16% (16) |
| Oral cavity | 33% (33) |
| Nasopharynx | 1% (1) |
| Oropharynx | 25% (25) |
| Larynx | 7% (7) |
| Thyroid and parathyroid | 2% (2) |
| Salivary gland | 11% (11) |
| Other | 5% (5) |
| Treatment (all diagnoses) | |
| Nonsurgical | 5% (5) |
| Preoperative/pretreatment | 12% (12) |
| Surgery alone | 40% (40) |
| Surgery followed by adjuvant radiation +/− chemotherapy | 32% (32) |
| Primary chemoradiation therapy alone | 5% (5) |
| Salvage surgery | 4% (4) |
| Other | 1% (2) |
| Treatment time course (malignancies only N = 73) | |
| Completed treatment | 54% (54) |
| Active treatment | 13% (13) |
| Awaiting treatment | 6% (6) |
a
Included squamous cell carcinoma, basal cell carcinoma, adenocarcinoma, melanoma, nonhodgkin's lymphoma, carcinoma ex pleomorphic adenoma, mucoepidermoid carcinoma, acinic cell carcinoma, adenoid cystic carcinoma, pleomorphic sarcoma, angiosarcoma, sebaceous carcinoma.
b
Included oral leukoplakia and dysplasia.
c
Included biopsy for lesions to rule out malignancy, pituitary adenoma, parathyroid adenoma, schwannoma, thyroid goiter, pleomorphic adenoma, globus sensation, chronic tonsillitis, odontogenic keratocyst, sialolith.